Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Q2 2023 Earnings Call Transcript August 1, 2023
Rigel Pharmaceuticals, Inc. reports earnings inline with expectations. Reported EPS is $-0.08 EPS, expectations were $-0.08.
Operator: Greetings, and welcome to the Rigel Pharmaceuticals Financial Conference Call for the Second Quarter of 2023. At this time, all participants are in a listen only mode. A brief question-and-answer session will follow the formal presentation. [Operator Instructions] As a...
